Health-related quality-of-life of patients treated with repotrectinib for neurotrophic tyrosine receptor kinase (NTRK)-positive advanced solid tumors: Results from TRIDENT-1 Meeting Abstract


Authors: Sherif, B.; Besse, B.; Solomon, B.; Bazhenova, L.; Kim, D. W.; Lin, J. J.; Wolf, J.; Popat, S.; Goto, K.; de Langen, A. J.; Springfeld, C.; Reynolds, M.; Odom, D.; Yuan, Y.; Lee, A.; Blum, S.; Thamake, S.; Ades, F.; Drilon, A.
Abstract Title: Health-related quality-of-life of patients treated with repotrectinib for neurotrophic tyrosine receptor kinase (NTRK)-positive advanced solid tumors: Results from TRIDENT-1
Meeting Title: ISPOR Europe 2023
Journal Title: Value in Health
Volume: 26
Issue: 12 Suppl.
Meeting Dates: 2023 Nov 12-15
Meeting Location: Copenhagen, Denmark
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2023-12-01
Start Page: S484
Language: English
DOI: 10.1016/j.jval.2023.09.2619
PROVIDER: manual
Notes: Meeting Abstract: PCR181
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    633 Drilon